Abbott acquires Tendyne Holdings
Clients Abbott Laboratories
Jones Day acted as tax counsel to Abbott Laboratories in connection with its $250 million acquisition of Tendyne Holdings, Inc., a private medical device company focused on developing minimally invasive mitral valve replacement therapies.